🇵🇭 Philippines

Philippines — regulatory context

Vet drug authorities

BAI (Bureau of Animal Industry) under Department of Agriculture — registers veterinary biologics / vaccines. FDA Philippines — handles veterinary pharmaceuticals via e-registration portal.

Anti-Dummy Law (RA 134)

Prohibits foreigners from using local "dummies" for restricted activities. Distribution requires local licensing under RA 10918 (Philippine Pharmacy Act).

FX rules

Bangko Sentral ng Pilipinas (BSP) Manual of Regulations — reporting for inflows/outflows > USD 500,000 equivalent. Liberalized hedging; AML per AMLA.

Multi-distributor permissibility

YES No statutory restriction; subject to Retail Trade Liberalization Act (RA 11595) which allows foreign-equity retail with PHP 25M+ paid-up capital. Distribution exclusivity is contractual.

Voidance risks

• Language law: English/Filipino accepted (English is co-official); courts fully enforce English contracts.
• Stamp duty: Documentary Stamp Tax — 1-1.5% ad valorem on originals over PHP 200; non-payment weakens enforceability but does not void.
• Anti-Dummy Law (RA 134): Prohibits foreign principal from using a Filipino "dummy" to circumvent foreign-equity caps in restricted activities — can void distribution arrangements that fail substance-over-form.
• RA 10918 (Pharmacy Act): Distribution of pharmaceuticals requires local licensed pharmacist; non-licensed distribution voids the activity.
• Civil Code formalities: Contracts over PHP 500 require writing (Statute of Frauds); electronic signatures valid under E-Commerce Act.
• Formalities: Philippines is Hague Apostille member since 2019.

GAPS to verify with Filipino local counsel

Specific BAI/FDA registration process flow, fees, timelines; LGU permit requirements for distributor.